bioRxivBioinformaticsPreprint
SRF-CLICAL: an approach for patient risk stratification using random forest models
Felipe A. SimãoiD, Reija HietaiD, Jane A. PulmaniD, Gabriele MadonnaiD, Paolo A. AsciertoiD, Rolf LewensohniD, Giuseppe Valentino MasucciiD
Abstract
An important part of good clinical care is identifying which patients have a high likelihood of experiencing adverse outcomes. Similarly, due to the significant impact cancer treatment can have on a patients quality of life, it is also important to properly identify which patients are likely to benefit from more aggressive treatment options. As such, models for predictive risk stratification can be extremely useful in clinical decision making. In this paper, we present, Survival Random Forest-Clinical Categorization Algorithm (SRF-CLICAL), a new method for patient risk stratification using random forests for survival, regression and classification. As a proof of concept, we demonstrate this method on two different cohorts of cancer patients.
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: trajectory inference
- approach: machine learning (classical)
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Predicting long-term multicategory cause of death in patients with prostate cancer: random forest versus multinomial model
Jianwei Wang, Fei Deng, … Lanjing Zhang·bioRxiv·Jan 3, 2020
- Towards machine learning fairness in classifying multicategory causes of deaths in colorectal or lung cancer patients
Catherine H. Feng, Fei Deng, … Lanjing Zhang·Briefings in BioinformaticsPeer-reviewed·Jul 1, 2025
- Integrative deep learning analysis improves colon adenocarcinoma patient stratification at risk for mortality
J. Zhou, A. Foroughi pour, … J. H. Chuang·bioRxiv·Jun 13, 2022
- A machine learning approach to predicting short-term mortality risk in patients starting chemotherapy
Aymen A. Elfiky, Maximilian Julius Pany, … Ziad Obermeyer·bioRxiv·Oct 19, 2017
- Development and Validation of a Nomogram Prognostic Model for Small-Cell Lung Cancer Patients
- Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multi-Omics Data Analysis
Aimin Jiang, Yewei Bao, … Linhui Wang·Oxidative Medicine and Cellular LongevityPeer-reviewed·Jan 1, 2022